in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—20 August 2013
5:48 AM MDT | August 20, 2013 | Deepti Ramesh
Russia’s largest pharmaceutical company to buy Singapore-based API supplier for $590 million Pharmstandard (Moscow), Russia’s leading pharmaceutical company, says it will acquire Bever Pharmaceutical (Singapore), a supplier of active pharmaceutical ingredients (APIs), for a total of $590 million. Russian businessman Alexander Shuster, a nonexecutive board member of Pharmstandard, currently owns 100% stake in Bever. The strategic rationale for the proposed acquisition includes securing a long-term supply of critical APIs for two flagship OTC brands of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee